Douglas Kirk Ways

CIK: 0001869391

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SPRB

SPRUCE BIOSCIENCES, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

SPRB
SPRUCE BIOSCIENCES, INC.
Dec 11, 2025
Exercise(M)
Direct
1.3K shares-
SPRB
SPRUCE BIOSCIENCES, INC.
Dec 11, 2025
Award(A)
Restricted Stock Units
Direct
5K shares-
SPRB
SPRUCE BIOSCIENCES, INC.
Dec 11, 2025
Award(A)
Stock Option (Right to Buy)
Direct
266 shares-
SPRB
SPRUCE BIOSCIENCES, INC.
Dec 11, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
266 shares-
SPRB
SPRUCE BIOSCIENCES, INC.
Dec 11, 2025
Award(A)
Stock Option (Right to Buy)
Direct
400 shares-
SPRB
SPRUCE BIOSCIENCES, INC.
Dec 11, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
400 shares-
SPRB
SPRUCE BIOSCIENCES, INC.
Jul 23, 2025
Award(A)
Stock Option (Right to Buy)
Direct
30K shares-

		Type	Shares	Price		Ownership
Dec 11, 2025	SPRB SPRUCE BIOSCIENCES, INC.	Exercise(M)	1,250	-	$0	Direct
Dec 11, 2025	SPRB SPRUCE BIOSCIENCES, INC.	Award(A) Restricted Stock Units	5,000	-	-	Direct
Dec 11, 2025	SPRB SPRUCE BIOSCIENCES, INC.	Award(A) Stock Option (Right to Buy)	266	-	-	Direct
Dec 11, 2025	SPRB SPRUCE BIOSCIENCES, INC.	Disposition(D) Stock Option (Right to Buy)	266	-	-	Direct
Dec 11, 2025	SPRB SPRUCE BIOSCIENCES, INC.	Award(A) Stock Option (Right to Buy)	400	-	-	Direct
Dec 11, 2025	SPRB SPRUCE BIOSCIENCES, INC.	Disposition(D) Stock Option (Right to Buy)	400	-	-	Direct
Jul 23, 2025	SPRB SPRUCE BIOSCIENCES, INC.	Award(A) Stock Option (Right to Buy)	30,000	-	-	Direct

1-7 of 7 transactions

About Ways Douglas Kirk

Ways Douglas Kirk (SEC CIK 0001869391) files insider reports with the SEC as Interim Chief Medical Officer of SPRUCE BIOSCIENCES, INC. (SPRB).

Signal8 holds 2 ownership filings by Ways Douglas Kirk, all Form 4s, filed between Jul 24, 2025 and Jan 21, 2026. Those filings report 7 transactions, from Jul 23, 2025 to Dec 11, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Ways Douglas Kirk's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Ways Douglas Kirk

Dec 11, 2025: Option exercise of SPRB shares (Form 4, code M).
Dec 11, 2025: Grants or awards of SPRB derivative securities (2 lines, Form 4, code A).
Dec 11, 2025: Disposition to issuer transaction of SPRB derivative securities (Form 4, code D).
Dec 11, 2025: Grant or award of SPRB derivative securities (Form 4, code A).
Dec 11, 2025: Disposition to issuer transaction of SPRB derivative securities (Form 4, code D).

Other insiders filing for SPRUCE BIOSCIENCES, INC. (SPRB)

Quartel Adrian W, Chief Medical Officer
Szwarcberg Javier B., CHIEF EXECUTIVE OFFICER
SPIEGELMAN DANIEL K, Director
SIMPSON CAMILLA V, Director
GREY MICHAEL G, Executive Chairman
Barretto-Ko Percival, Director

How to read Form 4 transaction codes